
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
Jungbunzlauer has recently started producing pure L(+)-lactic acid, sodium lactate, and potassium lactate by traditional fermentation of natural, non-GM carbohydrates.






